Subvenite Suspension
NDC Package 69102-418-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Subvenite (lamotrigine) suspension is lamotrigine is used alone or with other medications to prevent and control seizures. This formulation utilizes a suspension delivery system. Marketed by Owp Pharmaceuticals, Inc., this product is identified by NDC 69102-418 and is authorized under FDA application NDA218879.

Identification & Billing

NDC Package Code
69102-418-01
Package Description
1 BOTTLE in 1 PACKAGE / 240 mL in 1 BOTTLE
Product Code
69102-418
11-Digit Billing Format
69102041801
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Subvenite
Non-Proprietary Name
Lamotrigine
Substance Name
Lamotrigine
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
LAMOTRIGINE 10 mg/mL
Pharmacologic Class
Usage Information
Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Regulatory & Marketing

Labeler Name
Owp Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA218879
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69102-418). Click a package code to view its specific billing and regulatory data.

69102-418-02
2 BOTTLE in 1 PACKAGE / 240 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69102-418-01 identifies a specific commercial package of 1 bottle in 1 package / 240 ml in 1 bottle of Subvenite, a human prescription drug labeled by Owp Pharmaceuticals, Inc.. This suspension is formulated for oral use and contains lamotrigine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Owp Pharmaceuticals, Inc. on October 01, 2025. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

How is this Owp Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69102041801. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69102-418-01
11-Digit CMS (5-4-2)
69102-0418-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.